事件:2025 年8 月25 日,晶泰控股利用其基于AI+机器人的端到端人工智能药物发现平台,为DoveTree 选定的多个针对肿瘤、自身免疫性疾病及神经领域的靶点,发现和开发小分子及抗体候选药物,公司将在最终协议签署的10 日及180 日内分别获得5100 万美元及4900 万美元首付款,同时有资格获得金额达5,890,000,000 美元的潜在监管里程碑及商业里程碑付款,并有资格获得金额...
Source LinkDisclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.